📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
211 analysed today
FollowTelegram
211
Today
152,073
All-time analysed
43,617
Positive
6,746
Negative
92,863
Neutral
8,779
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
848 announcements match the current filters (relevance ≥ 5).
Birla Corp Commissions 1.4 MTPA Expansion at Kundanganj; Total Capacity Reaches 21.4 MTPA
Birla Corporation's wholly owned subsidiary, RCCPL Private Limited, has successfully commissioned the third production line at its Kundanganj grinding unit in Uttar Pradesh. This expansion adds 1.4 million tons of grinding capacity, bringing the company's total consolidated production capacity to 21.4 million tons. The project, which was initially announced in May 2024, is now operational as of March 23, 2026. This move is strategically designed to enhance the company's competitive footprint in the high-demand markets of central and eastern Uttar Pradesh.
Key Highlights
Successfully commissioned 3rd production line at the Kundanganj grinding unit in Uttar Pradesh
Added 1.4 million tons of incremental grinding capacity through subsidiary RCCPL Private Limited
Increased total consolidated production capacity of Birla Corporation to 21.4 million tons
Strengthens market position in key regions of central and eastern Uttar Pradesh
👀 What to Watch
Investors should monitor the capacity utilization and volume growth from this unit in the coming quarters as it will likely drive top-line growth. The expansion reinforces the company's growth trajectory in the lucrative North Indian cement market.
Birla Cable to Merge with Vindhya Telelinks; Share Exchange Ratio Set at 10:115
Birla Cable Limited has approved a scheme of amalgamation with Vindhya Telelinks Limited, which will result in the dissolution of Birla Cable. Shareholders of Birla Cable will receive 10 shares of Vindhya Telelinks for every 115 shares held. The merger consolidates the M.P. Birla Group's cable and EPC businesses, creating a unified entity with a combined 9-month turnover of approximately Rs. 3,118 crore. This strategic move aims to enhance operational efficiency, strengthen the balance sheet for large-scale infrastructure projects, and simplify the corporate structure.
Key Highlights
Share swap ratio: 10 shares of Vindhya Telelinks (FV Rs. 10) for every 115 shares of Birla Cable (FV Rs. 10).
Birla Cable reported a 9-month turnover of Rs. 557.01 crore and a net worth of Rs. 229.12 crore as of December 2025.
Vindhya Telelinks reported a standalone 9-month turnover of Rs. 2,561.27 crore and a net worth of Rs. 1,335.37 crore.
Post-merger, the total share capital of Vindhya Telelinks will expand from 1.18 crore to 1.39 crore shares.
Public shareholding in the merged entity (Vindhya Telelinks) will increase to 58.74% from 56.46%.
👀 What to Watch
Investors should calculate the implied value of Birla Cable based on Vindhya Telelinks' current market price using the 10:115 ratio to identify potential arbitrage. The merger is beneficial for long-term holders as it creates a larger entity with better bidding capacity for capital-intensive infrastructure projects.
SBI Raises Rs 6,051 Crore via Basel III Compliant Tier 2 Bonds at 7.05% Coupon
State Bank of India (SBI) has successfully raised Rs 6,051 crore through the allotment of Basel III compliant Tier 2 bonds. These unsecured, subordinated bonds carry a coupon rate of 7.05% and have a tenure of 10 years. The capital raised will help the bank strengthen its capital adequacy ratio and support its credit growth objectives. The bonds are scheduled for redemption on March 20, 2036, with interest payments made annually.
Key Highlights
Total fundraise of Rs 6,051 crore via Basel III compliant Tier 2 bonds
Fixed coupon rate of 7.05% per annum with annual interest payments
Instrument tenure of 10 years with final redemption date of March 20, 2036
Bonds issued at a face value of Rs 1 crore each and will be listed on BSE and NSE
👀 What to Watch
This capital infusion strengthens SBI's balance sheet and provides the necessary headroom for lending expansion. Long-term investors should view this as a positive step in maintaining the bank's capital buffers.
SBIN Receives Income Tax Demand Notice of ₹6,337.5 Crore for AY 2023-24
State Bank of India (SBIN) has received a significant tax demand notice of ₹6,337.5 crore, including interest, for the Assessment Year 2023-24. The demand follows scrutiny assessment proceedings where the Income Tax Department made disallowances on various grounds. The bank has clarified that it is already involved in litigation on similar grounds for previous years, indicating a recurring dispute. SBIN intends to contest the order before appellate authorities and states that the demand will not impact its current operations.
Key Highlights
Income Tax demand of ₹63,37,52,52,550 (approx. ₹6,337.5 crore) raised for AY 2023-24.
The demand includes interest and arises from disallowances made under Section 143(3) of the IT Act.
SBIN is already contesting similar tax disallowances from earlier years in various legal forums.
The bank plans to file an appeal against the order within the prescribed legal timelines.
Management confirms no immediate impact on the bank's operational activities or other business functions.
👀 What to Watch
Investors should monitor the outcome of the appellate proceedings as the amount is material, though such tax disputes are relatively common for large public sector banks. No immediate action is required as the bank is following standard legal procedures to contest the demand.
Hester Biosciences Credit Rating Downgraded to CARE BBB; Stable by CARE Ratings
CARE Ratings has downgraded Hester Biosciences' long-term bank facilities from 'CARE BBB+; Stable' to 'CARE BBB; Stable' and short-term ratings from 'A2' to 'A3+'. The downgrade follows a review of the company's FY25 audited and 9MFY26 unaudited financial performance. Management has labeled this downgrade as 'transitional,' pointing towards recent improvements in operating margins, ROCE, and debt coverage ratios post-September 2025. The company maintains adequate liquidity for its debt obligations and has recently secured a manufacturing license for the Avian Influenza H9N2 vaccine.
Key Highlights
Long-term bank facilities downgraded to CARE BBB; Stable from CARE BBB+; Stable
Short-term bank facilities downgraded to CARE A3+ from CARE A2
Total bank facilities rated by CARE Ratings amount to ₹131.47 crore
Management reports improved debt coverage indicators in H1FY26 despite the rating action
Company holds 75% global market share in PPR vaccine and 35% Indian market share in poultry vaccines
👀 What to Watch
Investors should exercise caution due to the credit downgrade, which may increase future borrowing costs. Monitor upcoming quarterly results to see if the management's claim of a 'transitional' phase reflects in actual bottom-line improvement and debt reduction.
SBI Subsidiary SBI Funds Management Files DRHP for IPO; SBI to Divest 6.3% Stake
State Bank of India's subsidiary, SBI Funds Management Limited (SBIFML), has filed a Draft Red Herring Prospectus (DRHP) for an Initial Public Offering (IPO). The IPO involves a total stake sale of 10.0013%, comprising 203,709,239 equity shares. SBI will sell a 6.3007% stake (128,334,397 shares) through an Offer for Sale (OFS), while its partner Amundi India Holding will sell 3.7006%. This move is a significant value-unlocking event for SBI, as SBIFML is one of India's largest asset management companies.
Key Highlights
SBIFML filed DRHP for an IPO of up to 203,709,239 equity shares representing 10.0013% of its capital.
SBI to sell 128,334,397 shares (6.3007% stake) via Offer for Sale (OFS).
Amundi India Holding to divest 75,374,842 shares (3.7006% stake) in the same IPO.
SBI's share count for the OFS was revised from 3.2 crore to 12.83 crore following a bonus share issuance.
The IPO remains subject to regulatory approvals from SEBI and market conditions.
👀 What to Watch
Investors should maintain a positive outlook on SBI as this IPO will unlock the market value of its AMC business and provide a capital boost. Monitor the final valuation and pricing of the SBIFML IPO to assess the exact impact on SBI's sum-of-the-parts (SOTP) valuation.
MobiKwik Appoints Anis Pathan as Chief Risk Officer Amid 3.2x UPI Growth
One MobiKwik Systems has appointed Anis Pathan as Chief Risk Officer to lead its Enterprise Risk Management framework. The appointment comes as the company scales rapidly, reporting a record Q3FY26 GMV of ₹48,100 crore and a 3.2x year-on-year surge in UPI transactions. Pathan brings 14 years of experience from NSDL Payments Bank and ICICI Lombard to manage risks across the group's new payment aggregation and stock broking licenses. This move aims to strengthen the security and scalability of the platform which currently serves over 186.6 million registered users.
Key Highlights
Appointment of Anis Pathan as CRO to oversee strategic, financial, and cyber risks.
Reported record-breaking Q3FY26 GMV of ₹48,100 crore.
Achieved a 3.2x year-on-year surge in UPI transaction volumes.
Maintains an 18% market share in the PPI wallet gross transaction value as of December 2025.
Expansion into new verticals following the acquisition of payment aggregation and stock broking licenses.
👀 What to Watch
Investors should monitor how the new risk leadership supports the company's transition into stock broking and lending. The strengthening of the management team is a positive sign for long-term regulatory compliance and operational stability.
MobiKwik Appoints Anis Pathan as Chief Risk Officer and Senior Management Personnel
One MobiKwik Systems Limited has announced the appointment of Mr. Anis Pathan as its Chief Risk Officer (CRO) and Senior Management Personnel, effective March 19, 2026. Mr. Pathan brings over 14 years of extensive experience in risk management across banking, payments, and microfinance sectors. His previous leadership roles include serving as CRO at NSDL Payments Bank and Head of Enterprise Risk Management at Oman Arab Bank. This strategic hire is intended to strengthen the company's risk governance framework as it continues to expand its fintech services.
Key Highlights
Appointment of Mr. Anis Pathan as Chief Risk Officer effective from March 19, 2026
Mr. Pathan has over 14 years of experience in banking, payments, insurance, and financial services
Previous leadership experience includes roles as CRO at NSDL Payments Bank and Chaitanya India Fin Credit
Holds prestigious certifications including FRM (GARP), CISA (ISACA), and SCR (Sustainability and Climate Risk)
Educational background includes an MBA in Finance from NMIMS and a Bachelor of Engineering
👀 What to Watch
Investors should view this as a positive move to bolster the company's risk management and regulatory compliance capabilities. No immediate portfolio action is required based on this management update.
SBI Raises ₹6,051 Crore via Basel III Compliant Tier 2 Bonds at 7.05% Coupon
State Bank of India (SBI) has successfully raised ₹6,051 crore through the issuance of Basel III compliant Tier 2 bonds. The bonds carry a coupon rate of 7.05% and have a tenure of 10 years, with a call option available after 5 years on March 20, 2031. The bidding process on the NSE EBP platform saw healthy participation with 47 bids received. This capital raise is intended to strengthen the bank's capital adequacy ratio and support its future credit growth.
Key Highlights
Raised ₹6,051 crore through unsecured, subordinated Basel III compliant Tier 2 bonds
Fixed coupon rate of 7.05% with a 10-year maturity period ending March 20, 2036
Includes an issuer call option after 5 years on March 20, 2031
Total of 47 bids received on the NSE Electronic Bidding Platform
Funds will bolster the bank's capital base to support long-term business expansion
👀 What to Watch
This fundraise strengthens SBI's balance sheet and capital adequacy, which is a positive signal for long-term stability. Investors should maintain their positions as the bank continues to optimize its capital structure at competitive rates.
SBI Raises ₹6,051 Crores via Tier 2 Bonds at 7.05% Coupon
State Bank of India (SBI) has successfully raised ₹6,051 crores through Basel III compliant Tier 2 bonds to bolster its capital position. The issuance features a competitive coupon rate of 7.05% for a 10-year tenor, with a call option available after 5 years. The offering was well-received by institutional investors, attracting bids approximately 2 times the base issue size of ₹5,000 crores. This capital infusion will support the bank's credit growth and maintain its robust capital adequacy ratios.
Key Highlights
Raised ₹6,051 crores at a coupon rate of 7.05% payable annually
Issue oversubscribed 2x against a base size of ₹5,000 crores with 47 institutional bids
Bonds rated AAA with stable outlook by CRISIL and India Ratings
Tenor of 10 years with a call option after 5 years and each anniversary thereafter
👀 What to Watch
Investors should view this as a positive development as it demonstrates SBI's ability to raise capital at fine pricing to support future growth. The strong oversubscription reflects high institutional confidence in the bank's credit profile.
A B Infrabuild Secures ₹48.68 Crore Railway Project from East Coast Railways
A B Infrabuild Limited has been awarded a significant contract worth approximately ₹48.68 Crore by the East Coast Railways. The project involves the construction of a Road Over Bridge (ROB) between Mandasa and Summadevi stations and technical services for nine level crossings. The scope includes feasibility studies, detailed project reports, and design development for infrastructure improvements. The entire project is scheduled to be completed within a 24-month timeframe.
Key Highlights
Total contract value stands at ₹48,67,75,280.22
Project awarded by East Coast Railways, Indian Railways for domestic execution
Scope includes construction of a Road Over Bridge and technical services for 09 Level Crossings
Execution timeline for the project is set at 24 months
Services include feasibility studies, DPR, and design development for drainage and rebuilding works
👀 What to Watch
Investors should view this as a positive development for the company's order book and revenue visibility over the next two years. Monitor the company's execution efficiency and margin maintenance for this railway infrastructure project.
IDBI Bank Clarifies on Reports of Scrapped Stake Sale; No Official Word from Govt
IDBI Bank has responded to an exchange query regarding news reports suggesting the Government of India (GOI) might scrap its 60.72% stake sale due to low bids. The bank stated it has received no official communication from the GOI regarding the cancellation of the disinvestment process. The bank emphasized that the process is confidential and managed entirely by the Department of Investment and Public Asset Management (DIPAM). Consequently, the bank is unable to confirm or deny the market rumors that recently led to a 13% drop in its stock price.
Key Highlights
IDBI Bank clarifies it has received no communication from the GOI regarding scrapping the disinvestment process.
The proposed sale involves a 60.72% stake, comprising 30.48% from the GOI and 30.24% from LIC.
The stock experienced a sharp decline of over 13% following rumors of low price bids and potential cancellation.
The bank maintains that the disinvestment is a confidential process handled by DIPAM and the bank has no role in negotiations.
The bank confirms it has disclosed all price-sensitive information to exchanges as per SEBI regulations.
👀 What to Watch
Investors should remain cautious as the bank's inability to definitively deny the rumor leaves room for continued volatility. Monitor official statements from DIPAM or the Ministry of Finance for the next steps on the bidding process.
Bikaji Foods Invests ₹40 Crore in Retail Subsidiary for QSR and Cafe Expansion
Bikaji Foods International has infused ₹40 crore into its wholly-owned subsidiary, Bikaji Foods Retail Limited (BFRL), to accelerate its growth in the retail and hospitality sectors. The investment was made by subscribing to 10,52,630 equity shares at a price of ₹380 per share, including a premium of ₹370. BFRL is focused on diversifying the company's reach into Quick Service Restaurants (QSRs), cafes, and food catering services. This move signifies Bikaji's strategic shift towards establishing a direct-to-consumer service footprint beyond its traditional snack manufacturing business.
Key Highlights
Total investment of ₹40 crore in wholly-owned subsidiary Bikaji Foods Retail Limited
Subscription of 10,52,630 equity shares at an aggregate price of ₹380 per share
Target entity BFRL is focused on QSR, cafes, restaurants, and food catering services
BFRL reported a turnover of ₹16.71 lakh for the financial year ended March 31, 2025
Post-investment, BFRL remains a 100% wholly-owned subsidiary of Bikaji Foods International
👀 What to Watch
Investors should view this as a positive step towards diversification into high-growth QSR and retail segments. Monitor the company's ability to scale these retail outlets effectively, as they typically offer higher margins but require different operational expertise than manufacturing.
ABINFRA Bags ₹66.96 Crore Road Over Bridge Project from East Coast Railways
A B Infrabuild Limited has secured a significant domestic contract from East Coast Railways valued at approximately ₹66.96 crore. The project involves the construction of a Road Over Bridge (ROB) between Icchapuram and Jhadupudi Railway Stations under the Khurdha Road Division. The company is mandated to complete the project within a 24-month timeframe. This win reinforces the company's expertise in railway infrastructure and provides clear revenue visibility for the next two fiscal years.
Key Highlights
Total contract value is ₹66,96,24,916.57 for railway infrastructure works
Awarded by East Coast Railways, Indian Railways, for construction of a Road Over Bridge (ROB)
Project execution timeline is set for 24 months
The scope includes construction of composite and T-beam girders at specific railway chainages
👀 What to Watch
Investors should view this as a positive development for the company's order book and track the execution progress over the next 24 months. Monitor upcoming quarterly results for signs of revenue recognition from this project.
Biocon Receives US FDA Approval for Liraglutide Injection (gVictoza)
Biocon Pharma Limited, a wholly-owned subsidiary of Biocon, has received US FDA approval for its Liraglutide Injection (gVictoza), 18 mg/3 mL. This product is indicated for the treatment of Type 2 Diabetes Mellitus in adults and children aged 10 and above. This approval follows the recent February 24, 2026, approval for gSaxenda, another Liraglutide variant. The move strengthens Biocon's portfolio of vertically integrated, complex drug products in the high-growth US market.
Key Highlights
Received US FDA approval for Liraglutide Injection (gVictoza) 18 mg/3 mL (6 mg/mL) prefilled pens.
Approval granted to Biocon Pharma Limited, a 100% subsidiary of Biocon Limited.
Follows a previous approval for Liraglutide injection (gSaxenda) received on February 24, 2026.
Targeted at the Type 2 Diabetes Mellitus market for patients aged 10 years and older.
Strengthens the company's position in vertically integrated, complex generic drug products.
👀 What to Watch
Investors should monitor the commercial launch and market share gains in the US GLP-1 segment, as this approval enhances Biocon's high-margin complex generics pipeline. The stock may see positive momentum due to the expansion of its diabetes care portfolio.
BIL Vyapar Limited Schedules 6th Committee of Creditors Meeting for March 13, 2026
BIL Vyapar Limited, which is currently undergoing the Corporate Insolvency Resolution Process (CIRP), has announced its sixth Committee of Creditors (CoC) meeting. The meeting is scheduled for March 13, 2026, to discuss matters related to the company's insolvency resolution. This follows the company's transition from its former identity as Binani Industries Limited. Investors should be aware that the outcome of these meetings will significantly dictate the company's future structure and debt obligations.
Key Highlights
The 6th meeting of the Committee of Creditors (CoC) is set for March 13, 2026.
The company is operating under the Corporate Insolvency Resolution Process (CIRP).
Disclosure is made in compliance with Regulation 30 and Schedule III of SEBI LODR Regulations.
BIL Vyapar Limited was formerly known as Binani Industries Limited (NSE: BILVYAPAR).
👀 What to Watch
Investors should remain highly cautious as equity holders typically face significant value erosion during insolvency proceedings. Monitor subsequent filings for details on any proposed resolution plans or liquidation orders.
SBI Life Receives ₹537.75 Crore Income Tax Demand for FY 2023-24
SBI Life Insurance has received an Income Tax Assessment Order for FY 2023-24 with a total demand of ₹537.75 crore. The demand includes a tax component of ₹441.24 crore and interest of ₹96.51 crore, primarily due to disallowed exemptions and the application of an incorrect tax rate. The company contends that the tax authority erroneously applied a 30% corporate tax rate instead of the applicable rate under section 115B. SBI Life intends to contest this order through an appeal and expects no material impact on its financial operations.
Key Highlights
Total tax demand of ₹537.75 crore received for the assessment of FY 2023-2024.
The demand consists of ₹441.24 crore in tax and ₹96.51 crore in interest, with no penalty imposed.
Key disputes include disallowed exemptions under sections 10(15) and 10(23AAB) and incorrect tax rate application.
Company will file an appeal before the Appellate Authority to contest the assessment order.
👀 What to Watch
Investors should monitor the outcome of the appeal process as tax litigations are common in the insurance sector but can involve significant sums. No immediate impact on earnings is expected as the company is contesting the demand.
BirlaNu Receives NCLT Approval for Merger of Five Subsidiaries
BirlaNu Limited (formerly HIL Limited) has received formal approval from the NCLT Kolkata for the amalgamation of five subsidiaries into the parent company. The entities include Crestia Polytech and its four step-down subsidiaries: Aditya Poly Industries, Aditya Polytechnic, Prabhu Sainath Polymers, and Topline Industries. Since these are wholly-owned or step-down subsidiaries, no new shares will be issued, and there will be no change in the management or control of BirlaNu. The restructuring is designed to eliminate redundancies and optimize the supply chain and procurement costs.
Key Highlights
NCLT Kolkata sanctioned the Scheme of Amalgamation via an order dated March 10, 2026.
Five subsidiaries, including Crestia Polytech and its step-down units, will be dissolved without winding up.
Zero new shares will be issued as the transferor companies are 100% directly or indirectly owned by BirlaNu.
The merger aims to reduce operational expenses and raw material costs through resource pooling.
BirlaNu will maintain a positive net worth post-merger with no impact on creditor rights.
👀 What to Watch
This is a positive internal restructuring that should lead to better operational margins through cost synergies. Investors should monitor the company's upcoming quarterly results for signs of improved administrative and supply chain efficiency.
Hester Biosciences to Divest 43.81% Stake in Texas Lifesciences for INR 92 Million
Hester Biosciences has announced the divestment of a 43.81% equity stake in its subsidiary, Texas Lifesciences Private Limited (TLPL), for a total consideration of INR 92 million. Following the sale to Ticop Life Private Limited, Hester will retain an 11% stake, and TLPL will cease to be a subsidiary. TLPL reported a turnover of INR 285.89 million in FY 2024-25, though over 97% of its sales were internal to Hester. This move allows Hester to unlock capital while maintaining a strategic business relationship with the entity.
Key Highlights
Divesting 43.81% stake out of 54.81% total holding in Texas Lifesciences Private Limited.
Total aggregate consideration for the sale is INR 92 million.
TLPL's FY 2024-25 turnover was INR 285.89 million with a net worth of INR 134.17 million.
Hester will maintain an 11% equity stake and continue business operations with TLPL.
The transaction is expected to be completed within three months from March 5, 2026.
👀 What to Watch
Investors should watch for the impact on consolidated margins since TLPL's internal sales were previously eliminated, and monitor the utilization of the INR 92 million proceeds.
Hester Biosciences to Divest 43.81% Stake in Texas Lifesciences for INR 92 Million
Hester Biosciences has approved the divestment of a 43.81% equity stake in its subsidiary, Texas Lifesciences Private Limited (TLPL), for a total consideration of INR 92 million. Following the sale to Ticop Life Private Limited, Hester will retain an 11% stake, and TLPL will no longer be a subsidiary. TLPL reported a turnover of INR 285.89 million in FY 2024-25, though over 97% of its sales were internal to Hester. The transaction is expected to be completed within three months and represents a strategic rationalization of the company's subsidiary portfolio.
Key Highlights
Divesting 43.81% stake in Texas Lifesciences for an aggregate value of INR 92 million
Hester will retain an 11% equity stake and continue business relations with TLPL
TLPL FY 2024-25 turnover was INR 285.89 million with a net worth of INR 134.17 million
Over 97% of TLPL's sales were internal to Hester, resulting in elimination during consolidation
The share transfer transaction is expected to be completed within a 3-month period
👀 What to Watch
Investors should note this as a portfolio streamlining move that unlocks INR 92 million in cash without significantly impacting consolidated revenue due to the high volume of internal sales. Monitor for any impact on procurement margins as TLPL moves from a subsidiary to an external supplier.
